Allakos Inc. (ALLK) Financials
Stock symbol ALLK is outdated, potentially delisted? Maybe it is available on other exchange?
ALLK Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2023 | 283.5 million | 62.5 million |
| June 30, 2023 | 319.2 million | 64.2 million |
| March 31, 2023 | 350.4 million | 70.0 million |
| Dec. 31, 2022 | 386.4 million | 76.0 million |
ALLK Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2023 | -29.6 million | 10.5 million |
| June 30, 2023 | -32.8 million | 9.8 million |
| March 31, 2023 | -30.4 million | 10.7 million |
| Dec. 31, 2022 | -47.1 million | 9.3 million |
ALLK Net Income
No data available :(
ALLK Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2023 | 193.9 million | - | 41.8 million |
| June 30, 2023 | 221.1 million | - | 39.7 million |
| March 31, 2023 | 252.6 million | - | 43.4 million |
| Dec. 31, 2022 | 279.8 million | - | 49.1 million |
ALLK Shares Outstanding
ALLK Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2023 | 107000 | 36.7 million | 11.5 million | - |
| June 30, 2023 | 252000 | 27.3 million | 10.5 million | - |
| March 31, 2023 | 267000 | 33.1 million | 12.0 million | - |
| Dec. 31, 2022 | 291000 | 35.4 million | 10.8 million | - |
ALLK Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2023 | - | 1.5 million |
| June 30, 2023 | - | 1.8 million |
| March 31, 2023 | - | 2.0 million |
| Dec. 31, 2022 | - | 2.0 million |
ALLK
Price: $0.33
52 week price:
Earnings Per Share: -1.30 USD
P/E Ratio: -0.25
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 140771
Market Capitalization: 29.4 million